17 November 2026
ADVERTISEMENT
ADVERTISEMENT

One ‘+’ Sparks Big Action: IAS Tukaram Mundhe Cracks Down on Cadila’s Aciloc Mix-Up

Maharashtra FDA has cancelled the sale and distribution licences of three Cadila warehouses after finding similar Aciloc brand names, wrong supplies and packaging violations.
Indian Masterminds Stories

Mumbai: Maharashtra Food and Drugs Commissioner Tukaram Mundhe, a 2005-batch Indian Administrative Service (IAS) officer, has cancelled the sale and distribution licences of three Cadila Pharmaceuticals warehouses in Thane, Pune and Nagpur over concerns related to similar drug names, wrong medicine supplies and packaging violations.

The action centres on two medicines sold under the Aciloc and Aciloc+ brand names. Although the names differ mainly by a “+” sign, the medicines contain different active ingredients. The FDA said such similarity could create confusion among patients, doctors, pharmacists and distributors and increase the risk of the wrong medicine being supplied.

Aciloc and Aciloc+ Contain Different Medicines

According to the FDA findings, Aciloc 150 and Aciloc 300 contain ranitidine, while Aciloc 150+ and Aciloc 300+ contain famotidine. The two sets therefore do not contain the same active pharmaceutical ingredient despite their closely similar brand names.

Both medicines are used to reduce stomach acid and treat acidity-related conditions. The FDA’s concern was that the similarity in branding could make it difficult to distinguish between products, particularly during ordering, dispensing and distribution.

Read also: Odisha IAS Transfers: 7 Officers Shifted; New Collectors Appointed in Nabarangpur and Nuapada

Wholesalers Received a Different Medicine

The issue became more serious after FDA inspections found cases where wholesalers had ordered one version but received another.

Pune wholesalers who had ordered Aciloc 150 and Aciloc 300 were supplied Aciloc 150+ and Aciloc 300+, according to reports based on the FDA action. The supplied products contained famotidine instead of the ranitidine in the versions ordered.

This raised concerns about the possibility of a medicine being dispensed with a different active ingredient from the one ordered or expected.

The FDA subsequently prohibited the concerned stock from sale and distribution during the proceedings.

Three Cadila Warehouses Face Action

The action covers Cadila Pharmaceuticals’ carrying and forwarding agent (CFA) warehouses at:

  • Bhiwandi in Thane district
  • Wadki in Pune
  • Nimji in Nagpur district

The FDA conducted inspections at the three facilities in July 2026. Officials found products carrying the Aciloc brand but containing different active ingredients.

Following the proceedings, the FDA cancelled the sale and distribution licences of the three warehouses.

Packaging Rules Also Violated

The FDA also found problems with the packaging of the famotidine products.

Under the applicable Drugs and Cosmetics Rules, 1945, famotidine tablets were required to be sold in packs of 14 tablets, according to the reported FDA findings. However, inspectors found Aciloc 150+ packs containing 30 tablets and Aciloc 300+ packs containing 20 tablets.

The packaging issue added another layer to the regulatory concerns surrounding the products.

FDA Commissioner Urges Consumers to Check Labels

FDA Commissioner Tukaram Mundhe stressed that medicine names should not create confusion for patients, doctors or distributors.

The department has also advised consumers to pay attention to the generic name, strength and other details printed on the medicine pack, rather than relying only on the brand name. Patients should also ensure that chemists provide medicines according to the doctor’s prescription.

The advice is particularly relevant when different medicines have nearly identical brand names.

Why Similar Drug Names Matter

Brand-name similarity can become a safety concern when medicines contain different active ingredients. A small difference in packaging or naming may not always be obvious during ordering or dispensing, especially in a busy pharmaceutical supply chain.

In this case, the difference between Aciloc and Aciloc+ was mainly the “+” symbol, while the active ingredients were different. The FDA’s action therefore highlights the importance of clear product identification at every stage, from manufacturing and warehousing to wholesale distribution and retail sale.

The Maharashtra FDA has been carrying out wider enforcement drives under Mundhe, with the department saying its focus is on improving food and drug safety and ensuring compliance across the supply chain.

Focus on Safer Medicine Distribution

The Cadila action puts the spotlight on an important but often overlooked part of healthcare — the safe movement of medicines from manufacturers to patients.

For consumers, the case reinforces the need to check the medicine’s generic name and strength and follow the prescription carefully. For pharmaceutical companies and distributors, it highlights the importance of accurate branding, packaging, stock handling and order fulfilment.

The Maharashtra FDA’s action against the three Cadila warehouses is therefore not only about one brand-name dispute. It also underlines the larger responsibility of the pharmaceutical supply chain to ensure that patients receive the medicine they are prescribed, with the correct active ingredient, strength and packaging.

Read also: DoPT Updates: SK Jha Gets Extension Till Retirement; Alok Pande Repatriated From DIPAM After HAG+ Promotion


Indian Masterminds Stories
Join our WhatsApp Channel
ADVERTISEMENT
ADVERTISEMENT
Related Stories
ADVERTISEMENT
ADVERTISEMENT
NEWS
Shri Ram Raja Temple Treasury
Madhya Pradesh: Shri Ram Raja Temple Treasury Safe, Niwari Administration Rejects Lock Tampering Reports 
Senior Citizen Welfare
MoD, MoSJE Sign MoU to Boost Senior Citizen Welfare in Cantonment Areas; 8 New Day Care Centres Planned
WCL Mine Safety Fortnight
WCL Launches Annual Mine Safety Fortnight 2026, CMD Calls for 100% Safety Compliance 
BSE
BSE BANKEX Becomes First Indian Sectoral Index Futures Contract Approved by US CFTC
WCL iFOREST MoU
WCL Signs MoU with iFOREST to Promote Sustainable Mine Closure and Just Transition in Coal Mining Regions
NTPC
NTPC Subsidiary NVVN Awards $75 Million EPC Contract for 57 MW Natural Gas-Based Power Plant in Andaman 
MP High Court restores full powers of the State Transport Authority, paving the way for 280 bus routes and interstate transport permits
Madhya Pradesh State Transport Authority Gets Full Legal Powers, 280 Bus Routes to Gain Momentum 
DFCCIL FIDIC Asia-Pacific Project Award 2026
DFCCIL Wins FIDIC Asia-Pacific Project Award 2026 for Excellence in Railway Engineering
ADVERTISEMENT
ADVERTISEMENT
Videos
Five years after Kargil, India sent its cricketing heroes to Pakistan where terrorism posed a deadly threat. The man guarding them, former Special Director of Intelligence Bureau, Mr. Yashovardhan Azad, reveals what all went behind the scenes during that crucial tour. 
Trust No One, Said His Instinct in Pakistan
Gajendra Singh Shekhawat
How India Plans to Boost Tourism, Create Jobs and Ease Overcrowding : Gajendra Singh Shekhawat on the Road to 2047
Dr Saket Badola IFS
Beyond Tigers and Safaris: How Corbett Literature Festival Wants to Change the Conservation Conversation
ADVERTISEMENT
UPSC Stories
Gautam UPSC
He Studied at 4 AM in a 10×10 Mumbai Slum Room; Today, Gautam Padibhar is an Indian Forest Service Officer
Meet IFS officer Gautam Padhibhar, a 2023-batch Chhattisgarh cadre officer who rose from financial hardship...
Aniket Sagar ICoAS
No Coaching, Full-Time Job and Two Attempts: How Aniket Sagar Cleared ICoAS
Aniket Sagar, a chartered accountant from Bundelkhand, cleared UPSC ICoAS 2025 after working at PwC,...
IDAS Himanshu Tembhekar
Should UPSC Aspirants Give Up Their Hobbies? IDAS Officer Himanshu Tembhekar Explains
Should UPSC aspirants give up their hobbies? IDAS officer Himanshu Tembhekar explains how hobbies help...
CSR NEWS
Coal India CSR Programme
Coal India Organises CSR Programme to Align Mining Operations with Community Development 
Initiative Aims to Strengthen CSR Implementation in Coal-Bearing Regions and Improve Community Well-Being...
hurl
HURL Signs MoU with Injot Trust to Launch Project ANGOR for Children's Education in Assam
The three-year CSR initiative will cover five locations in Assam, focusing on holistic education, digital...
cmpdil
CMPDIL Partners with Tata Steel Foundation to Upgrade Technical Education at ITI Tamar 
The project will modernise training infrastructure with robotic welding technology, digital learning...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Latest
Shri Ram Raja Temple Treasury
Madhya Pradesh: Shri Ram Raja Temple Treasury Safe, Niwari Administration Rejects Lock Tampering Reports 
Senior Citizen Welfare
MoD, MoSJE Sign MoU to Boost Senior Citizen Welfare in Cantonment Areas; 8 New Day Care Centres Planned
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Videos
Five years after Kargil, India sent its cricketing heroes to Pakistan where terrorism posed a deadly threat. The man guarding them, former Special Director of Intelligence Bureau, Mr. Yashovardhan Azad, reveals what all went behind the scenes during that crucial tour. 
Gajendra Singh Shekhawat
Dr Saket Badola IFS
ADVERTISEMENT
ADVERTISEMENT